Free Trial

Morgan Stanley Emerging Markets Debt Fund (MSD) Competitors

Morgan Stanley Emerging Markets Debt Fund logo
$6.72 +0.10 (+1.51%)
Closing price 10/15/2026 03:58 PM Eastern
Extended Trading
$6.72 +0.00 (+0.07%)
As of 10/15/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

MSD vs. GAMI, AEXA, HQL, NCDL, and NOAH

Should you buy Morgan Stanley Emerging Markets Debt Fund stock or one of its competitors? Morgan Stanley Emerging Markets Debt Fund's main competitors and comparable companies include GAMCO Investors (GAMI), American Exceptionalism Acquisition (AEXA), abrdn Life Sciences Investors (HQL), Nuveen Churchill Direct Lending (NCDL), and Noah (NOAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "capital markets" industry.

How does Morgan Stanley Emerging Markets Debt Fund compare to GAMCO Investors?

GAMCO Investors (NYSE:GAMI) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, media sentiment, valuation, analyst recommendations and profitability.

GAMCO Investors has a beta of 0.58, suggesting that its stock price is 42% less volatile than the broader market. Comparatively, Morgan Stanley Emerging Markets Debt Fund has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market.

GAMCO Investors pays an annual dividend of $0.40 per share and has a dividend yield of 1.6%. Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.58 per share and has a dividend yield of 8.6%. GAMCO Investors pays out 12.7% of its earnings in the form of a dividend. GAMCO Investors has raised its dividend for 1 consecutive years.

3.3% of GAMCO Investors shares are owned by institutional investors. 81.2% of GAMCO Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, GAMCO Investors' average media sentiment score of 0.00 beat Morgan Stanley Emerging Markets Debt Fund's score of -0.72 indicating that GAMCO Investors is being referred to more favorably in the media.

Company Overall Sentiment
GAMCO Investors Neutral
Morgan Stanley Emerging Markets Debt Fund Negative

GAMCO Investors has a net margin of 27.86% compared to Morgan Stanley Emerging Markets Debt Fund's net margin of 0.00%. GAMCO Investors' return on equity of 36.01% beat Morgan Stanley Emerging Markets Debt Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
GAMCO Investors27.86% 36.01% 23.05%
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

GAMCO Investors has higher revenue and earnings than Morgan Stanley Emerging Markets Debt Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GAMCO Investors$231.40M2.37$64.46M$3.168.07
Morgan Stanley Emerging Markets Debt FundN/AN/AN/AN/AN/A

Summary

GAMCO Investors beats Morgan Stanley Emerging Markets Debt Fund on 9 of the 11 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to American Exceptionalism Acquisition?

American Exceptionalism Acquisition (NYSE:AEXA) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, media sentiment, dividends, earnings, risk, analyst recommendations, profitability and valuation.

Company Net Margins Return on Equity Return on Assets
American Exceptionalism AcquisitionN/A N/A N/A
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
American Exceptionalism Acquisition
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Morgan Stanley Emerging Markets Debt Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
American Exceptionalism AcquisitionN/AN/A-$7.20M$0.1289.53
Morgan Stanley Emerging Markets Debt FundN/AN/AN/AN/AN/A

In the previous week, American Exceptionalism Acquisition had 2 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 2 mentions for American Exceptionalism Acquisition and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. American Exceptionalism Acquisition's average media sentiment score of 1.00 beat Morgan Stanley Emerging Markets Debt Fund's score of -0.72 indicating that American Exceptionalism Acquisition is being referred to more favorably in the media.

Summary

American Exceptionalism Acquisition beats Morgan Stanley Emerging Markets Debt Fund on 3 of the 3 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to abrdn Life Sciences Investors?

abrdn Life Sciences Investors (NYSE:HQL) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

abrdn Life Sciences Investors has a beta of 0.77, meaning that its share price is 23% less volatile than the broader market. Comparatively, Morgan Stanley Emerging Markets Debt Fund has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
abrdn Life Sciences InvestorsN/AN/AN/AN/AN/A
Morgan Stanley Emerging Markets Debt FundN/AN/AN/AN/AN/A

In the previous week, abrdn Life Sciences Investors had 1 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 1 mentions for abrdn Life Sciences Investors and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Morgan Stanley Emerging Markets Debt Fund's average media sentiment score of -0.72 beat abrdn Life Sciences Investors' score of -1.00 indicating that Morgan Stanley Emerging Markets Debt Fund is being referred to more favorably in the news media.

abrdn Life Sciences Investors pays an annual dividend of $2.24 per share and has a dividend yield of 13.0%. Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.58 per share and has a dividend yield of 8.6%.

32.2% of abrdn Life Sciences Investors shares are owned by institutional investors. 10.1% of abrdn Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
abrdn Life Sciences InvestorsN/A N/A N/A
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

Summary

abrdn Life Sciences Investors beats Morgan Stanley Emerging Markets Debt Fund on 5 of the 6 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to Nuveen Churchill Direct Lending?

Nuveen Churchill Direct Lending (NYSE:NCDL) and Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) are both small-cap finance companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, institutional ownership, earnings, profitability, risk, analyst recommendations and dividends.

In the previous week, Nuveen Churchill Direct Lending had 1 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 1 mentions for Nuveen Churchill Direct Lending and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Nuveen Churchill Direct Lending's average media sentiment score of 0.00 beat Morgan Stanley Emerging Markets Debt Fund's score of -0.72 indicating that Nuveen Churchill Direct Lending is being referred to more favorably in the media.

Nuveen Churchill Direct Lending has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market. Comparatively, Morgan Stanley Emerging Markets Debt Fund has a beta of 0.55, meaning that its share price is 45% less volatile than the broader market.

Nuveen Churchill Direct Lending pays an annual dividend of $1.44 per share and has a dividend yield of 13.3%. Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.58 per share and has a dividend yield of 8.6%. Nuveen Churchill Direct Lending pays out 151.6% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Nuveen Churchill Direct Lending has higher revenue and earnings than Morgan Stanley Emerging Markets Debt Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nuveen Churchill Direct Lending$207.86M2.58$65.61M$0.9511.43
Morgan Stanley Emerging Markets Debt FundN/AN/AN/AN/AN/A

Nuveen Churchill Direct Lending has a net margin of 24.44% compared to Morgan Stanley Emerging Markets Debt Fund's net margin of 0.00%. Nuveen Churchill Direct Lending's return on equity of 9.60% beat Morgan Stanley Emerging Markets Debt Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Nuveen Churchill Direct Lending24.44% 9.60% 4.10%
Morgan Stanley Emerging Markets Debt Fund N/A N/A N/A

Nuveen Churchill Direct Lending presently has a consensus price target of $13.63, indicating a potential upside of 25.52%. Given Nuveen Churchill Direct Lending's stronger consensus rating and higher possible upside, equities research analysts clearly believe Nuveen Churchill Direct Lending is more favorable than Morgan Stanley Emerging Markets Debt Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nuveen Churchill Direct Lending
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20
Morgan Stanley Emerging Markets Debt Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

Nuveen Churchill Direct Lending beats Morgan Stanley Emerging Markets Debt Fund on 10 of the 11 factors compared between the two stocks.

How does Morgan Stanley Emerging Markets Debt Fund compare to Noah?

Morgan Stanley Emerging Markets Debt Fund (NYSE:MSD) and Noah (NYSE:NOAH) are both small-cap finance companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, earnings, dividends, profitability, analyst recommendations, valuation and risk.

Noah has higher revenue and earnings than Morgan Stanley Emerging Markets Debt Fund.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Morgan Stanley Emerging Markets Debt FundN/AN/AN/AN/AN/A
Noah$373.26M1.34$79.92M$1.235.96

Noah has a consensus target price of $9.85, indicating a potential upside of 34.29%. Given Noah's stronger consensus rating and higher probable upside, analysts clearly believe Noah is more favorable than Morgan Stanley Emerging Markets Debt Fund.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Morgan Stanley Emerging Markets Debt Fund
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Noah
0 Sell rating(s)
4 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Noah had 2 more articles in the media than Morgan Stanley Emerging Markets Debt Fund. MarketBeat recorded 2 mentions for Noah and 0 mentions for Morgan Stanley Emerging Markets Debt Fund. Noah's average media sentiment score of -0.13 beat Morgan Stanley Emerging Markets Debt Fund's score of -0.72 indicating that Noah is being referred to more favorably in the news media.

Company Overall Sentiment
Morgan Stanley Emerging Markets Debt Fund Negative
Noah Neutral

Morgan Stanley Emerging Markets Debt Fund pays an annual dividend of $0.58 per share and has a dividend yield of 8.6%. Noah pays an annual dividend of $0.63 per share and has a dividend yield of 8.6%. Noah pays out 51.2% of its earnings in the form of a dividend.

Morgan Stanley Emerging Markets Debt Fund has a beta of 0.55, suggesting that its stock price is 45% less volatile than the broader market. Comparatively, Noah has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

42.7% of Noah shares are owned by institutional investors. 47.2% of Noah shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Noah has a net margin of 22.57% compared to Morgan Stanley Emerging Markets Debt Fund's net margin of 0.00%. Noah's return on equity of 6.37% beat Morgan Stanley Emerging Markets Debt Fund's return on equity.

Company Net Margins Return on Equity Return on Assets
Morgan Stanley Emerging Markets Debt FundN/A N/A N/A
Noah 22.57%6.37%5.38%

Summary

Noah beats Morgan Stanley Emerging Markets Debt Fund on 11 of the 13 factors compared between the two stocks.

Get Morgan Stanley Emerging Markets Debt Fund News Delivered to You Automatically

Sign up to receive the latest news and ratings for MSD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MSD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MSD vs. The Competition

MetricMorgan Stanley Emerging Markets Debt FundCapital Markets IndustryFinance SectorNYSE Exchange
Market Cap$134.28M$5.06B$13.46B$22.98B
Dividend Yield8.84%7.64%6.11%3.73%
P/E RatioN/A27.7622.5522.53
Price / SalesN/A1,210.74490.0124.18
Price / CashN/A47.4742.3435.33
Price / BookN/A3.462.704.72
Net IncomeN/A$415.07M$1.32B$1.07B
7 Day Performance-0.81%-0.65%-0.28%-0.26%
1 Month Performance-5.08%-1.27%-1.92%-2.04%
1 Year Performance-7.05%8.31%10.55%7.05%

Morgan Stanley Emerging Markets Debt Fund Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MSD
Morgan Stanley Emerging Markets Debt Fund
N/A$6.72
+1.5%
N/A-8.1%$134.28MN/AN/AN/A
GAMI
GAMCO Investors
N/A$25.00
0.0%
N/A+6.3%$538.40M$231.40M9.47170
AEXA
American Exceptionalism Acquisition
N/A$10.87
-0.4%
N/A-8.5%$537.83MN/A90.622
HQL
abrdn Life Sciences Investors
N/A$17.57
+0.1%
N/A+4.8%$534.24MN/AN/AN/A
NCDL
Nuveen Churchill Direct Lending
3.3255 of 5 stars
$10.72
-1.7%
$13.63
+27.2%
-21.7%$529.21M$207.86M11.28N/A

Related Companies and Tools


This page (NYSE:MSD) was last updated on 10/16/2026 by MarketBeat.com Staff.
From Our Partners